Nu Skin Enterprises, Inc. (NUS) Income Statement
NUS 2025 at a glance
Fiscal year ended December 31, 2025 · U.S. dollarsNUS revenue and net income
Where NUS's revenue goes
2025Each bar shows an amount and its share of revenue. NUS kept 10.8% of revenue as net income.
NUS profit margins
NUS growth rates
to 2025| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Revenue | −14.3% | −12.6% | −10.5% | −4.1% |
| Gross profit | −12.7% | −13.5% | −11.7% | −5.2% |
| Operating income | — | −6.4% | −18.8% | −9.4% |
| Net income | — | +15.2% | −3.5% | +1.9% |
| EPS (diluted) | +276.5% | +3.5% | −2.6% | +1.3% |
1-year change and average annual growth (CAGR) over 3, 5 and 10 fiscal years. "—" when a starting value was zero or negative.
NUS quarterly EPS vs estimates
Nu Skin Enterprises beat the analyst EPS estimate in 5 of the last 8 quarters. Next report: November 5, 2026 (estimate $0.21).
NUS income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.49B | $1.73B | $1.97B | $2.23B | $2.70B | $2.58B | $2.42B | $2.68B | $2.28B | $2.21B |
| Cost of revenue | $453.8M | $550.2M | $611.9M | $630.9M | $675.2M | $658.0M | $581.4M | $634.1M | $502.1M | $500.5M |
| Gross profit | $1.03B | $1.18B | $1.36B | $1.59B | $2.02B | $1.92B | $1.84B | $2.04B | $1.78B | $1.71B |
| Research & development | — | $13.0M | $22.6M | $23.3M | $27.2M | $23.3M | $30.1M | $23.0M | $22.0M | $24.3M |
| Sales, general & admin | $940.5M | $1.13B | $1.29B | $1.44B | $1.73B | $1.67B | $1.57B | $1.73B | $1.50B | $1.48B |
| Total operating expenses | $940.5M | $1.33B | $1.31B | $1.48B | $1.79B | $1.67B | $1.57B | $1.73B | $1.50B | $1.48B |
| Operating income | $90.9M | −$151.6M | $48.3M | $110.8M | $234.0M | $257.6M | $267.4M | $240.9M | $274.5M | $231.1M |
| Interest income | $42.0M | $26.4M | $25.6M | $13.5M | $11.0M | $13.1M | $19.2M | $21.8M | $7.9M | $15.6M |
| Interest expense | $13.9M | $26.4M | $25.6M | $21.9M | $11.0M | $13.1M | $19.2M | $0 | $0 | $0 |
| Income before taxes | $196.2M | −$175.1M | $26.6M | $89.0M | $232.5M | $256.2M | $255.2M | $219.7M | $265.6M | $212.8M |
| Income taxes | $36.0M | −$28.5M | $18.0M | −$15.8M | $85.2M | $64.9M | $81.6M | $97.8M | $136.1M | $69.8M |
| Net income | $160.2M | −$146.6M | $8.6M | $104.8M | $147.3M | $191.4M | $173.6M | $121.9M | $129.4M | $143.1M |
| EBITDA | $262.4M | −$78.8M | $204.7M | $175.0M | $319.8M | $331.6M | $344.1M | $302.7M | $346.0M | $303.5M |
| EPS (diluted) | $3.20 | $0.85 | $1.84 | $2.89 | $3.91 | $3.65 | $3.11 | $3.97 | $3.24 | $2.89 |
| Gross margin | 69.4% | 68.2% | 68.9% | 71.7% | 75.0% | 74.5% | 76.0% | 76.3% | 78.0% | 77.3% |
| Operating margin | 6.1% | −8.8% | 2.5% | 5.0% | 8.7% | 10.0% | 11.0% | 9.0% | 12.0% | 10.5% |
| Net margin | 10.8% | −8.5% | 0.4% | 4.7% | 5.5% | 7.4% | 7.2% | 4.5% | 5.7% | 6.5% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $320.1M | $320.6M | $370.3M | $364.2M | $386.1M | $364.5M | $445.6M | $430.1M | $439.1M | $417.3M | $488.6M | $498.8M |
| Cost of revenue | $101.8M | $106.1M | $108.3M | $107.5M | $120.4M | $117.5M | $166.4M | $128.7M | $131.9M | $123.2M | $136.2M | $206.5M |
| Gross profit | $218.3M | $214.5M | $262.0M | $256.7M | $265.7M | $247.0M | $279.1M | $301.5M | $307.2M | $294.1M | $352.4M | $292.3M |
| Research & development | — | — | $10.8M | — | — | — | $13.0M | — | — | — | $22.6M | — |
| Sales, general & admin | $198.8M | $208.6M | $107.4M | $235.1M | $235.0M | $231.8M | $286.4M | $283.2M | $283.4M | $278.1M | $145.0M | $318.6M |
| Total operating expenses | $277.6M | $208.6M | $238.7M | $235.1M | $235.0M | $256.9M | $332.2M | $283.2M | $432.7M | $285.2M | $336.4M | $318.6M |
| Operating income | −$59.3M | $5.9M | $23.2M | $21.6M | $30.8M | −$9.9M | −$53.1M | $18.2M | −$125.6M | $8.8M | $16.1M | −$26.4M |
| Interest income | — | — | $4.0M | $4.1M | $2.5M | $31.4M | $5.9M | $6.5M | — | — | — | — |
| Interest expense | $3.3M | $4.2M | $4.0M | $4.1M | $2.5M | $3.3M | $5.9M | $6.5M | $6.7M | $7.3M | $1.5M | $7.5M |
| Income before taxes | −$63.2M | $2.6M | $18.2M | $16.0M | $27.4M | $134.6M | −$57.8M | $13.3M | −$131.6M | $1.1M | $9.3M | −$34.5M |
| Income taxes | $186.6M | $763,000 | $3.7M | −$1.1M | $6.3M | $27.1M | −$21.7M | $5.0M | −$13.4M | $1.6M | $2.0M | $2.5M |
| Net income | −$249.8M | $1.8M | $14.5M | $17.1M | $21.1M | $107.5M | −$36.1M | $8.3M | −$118.3M | −$533,000 | $7.3M | −$37.0M |
| EBITDA | −$47.2M | $19.2M | $35.1M | $32.2M | $43.0M | $152.1M | −$35.5M | $37.1M | −$107.3M | $26.9M | $26.6M | −$16.3M |
| EPS (diluted) | $0.20 | $0.14 | $0.29 | $0.34 | $0.43 | $2.14 | $0.38 | $0.17 | $0.21 | $0.09 | $0.37 | $0.56 |
| Gross margin | 68.2% | 66.9% | 70.7% | 70.5% | 68.8% | 67.8% | 62.7% | 70.1% | 70.0% | 70.5% | 72.1% | 58.6% |
| Operating margin | −18.5% | 1.8% | 6.3% | 5.9% | 8.0% | −2.7% | −11.9% | 4.2% | −28.6% | 2.1% | 3.3% | −5.3% |
| Net margin | −78.0% | 0.6% | 3.9% | 4.7% | 5.5% | 29.5% | −8.1% | 1.9% | −26.9% | −0.1% | 1.5% | −7.4% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported in NUS's financial statements (latest annual report filed February 13, 2026); data from EODHD. Sales, general & administrative expenses include sales and marketing.
NUS financial results
In fiscal year 2025 (ended December 31, 2025), Nu Skin Enterprises reported revenue of $1.5 billion, down 14.3% from the year before. It had net income of $160.2 million, a net profit margin of 10.8%. Diluted earnings per share came to $3.20. Over five years revenue grew at an average rate of −10.5% a year.
See the NUS stock overview for the latest quote and news, or the NUS chart for price history and technical indicators.
NUS income statement FAQ
What is Nu Skin Enterprises's annual revenue?
Nu Skin Enterprises reported total revenue of $1.5 billion for fiscal year 2025, which ended on December 31, 2025. That was down 14.3% from $1.7 billion the previous year.
Is Nu Skin Enterprises profitable?
Yes. Nu Skin Enterprises reported net income of $160.2 million in fiscal 2025, a net profit margin of 10.8%; its operating margin was 6.1%.
What is Nu Skin Enterprises's gross margin?
Nu Skin Enterprises's gross margin was 69.4% in fiscal 2025: for every $100 of revenue, Nu Skin Enterprises kept $69 after the direct cost of its products and services.
How fast is Nu Skin Enterprises growing?
Revenue grew −10.5% a year on average over the last five fiscal years, from $2.6 billion to $1.5 billion.
What are Nu Skin Enterprises's earnings per share?
Nu Skin Enterprises earned $3.20 per diluted share in fiscal 2025, compared with $0.85 a year earlier.
When will Nu Skin Enterprises report its next earnings?
Nu Skin Enterprises is expected to report results for the quarter ending September 30, 2026 on November 5, 2026 after the market closes.
When does Nu Skin Enterprises's fiscal year end?
Nu Skin Enterprises's fiscal year ends in December. The latest annual report covers the year ended December 31, 2025 and was filed on February 13, 2026.